These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 26400354)
21. ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy. Rumiato E; Cavallin F; Boldrin E; Cagol M; Alfieri R; Basso D; Castoro C; Ancona E; Amadori A; Ruol A; Saggioro D Pharmacogenet Genomics; 2013 Nov; 23(11):597-604. PubMed ID: 23962907 [TBL] [Abstract][Full Text] [Related]
22. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival. Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974 [TBL] [Abstract][Full Text] [Related]
23. Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer. Yu WH; Wang YX; Guo JQ; Wang YL; Zheng JS; Zhu KX Genet Mol Res; 2015 Dec; 14(4):17529-35. PubMed ID: 26782397 [TBL] [Abstract][Full Text] [Related]
24. Genetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients. Zhong G; Li HK; Shan T; Zhang N Genet Mol Res; 2015 Dec; 14(4):17228-34. PubMed ID: 26681216 [TBL] [Abstract][Full Text] [Related]
25. Role of ERCC2 and ERCC3 gene polymorphisms in the development of osteosarcoma. Ma X; Zhang Y; Sun TS; Yao JH Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051024 [TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population. Liu D; Liu X Medicine (Baltimore); 2018 Dec; 97(49):e13358. PubMed ID: 30544402 [TBL] [Abstract][Full Text] [Related]
27. Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer. He MG; Zheng K; Tan D; Wang ZX Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051038 [TBL] [Abstract][Full Text] [Related]
28. ERCC1 and ERCC2 variants predict survival in gastric cancer patients. Li Y; Liu Z; Liu H; Wang LE; Tan D; Ajani JA; Wei QY PLoS One; 2013; 8(9):e71994. PubMed ID: 24023723 [TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer. Tang Y; Zhang R; Li Y; Xu S; Wang H; Xu J; Xiao L; Wang Y; Du J; Huang Y; Su T BMC Cancer; 2021 Jul; 21(1):842. PubMed ID: 34284736 [TBL] [Abstract][Full Text] [Related]
30. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA. Lu B; Li J; Gao Q; Yu W; Yang Q; Li X Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975 [TBL] [Abstract][Full Text] [Related]
31. Study of association between pre-senile cataracts and rs11615 of ERCC1, rs13181 of ERCC2, and rs25487 of XRCC1 polymorphisms in a Spanish population. López-Valverde G; Garcia-Martin E; Fernández-Mateos J; Cruz-González F; Larrosa-Povés JM; Polo-Llorens V; Pablo-Júlvez LE; González-Sarmiento R Ophthalmic Genet; 2017; 38(4):314-319. PubMed ID: 27668351 [TBL] [Abstract][Full Text] [Related]
32. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors. Geng P; Ou J; Li J; Liao Y; Wang N; Xie G; Sa R; Liu C; Xiang L; Liang H Mol Neurobiol; 2016 May; 53(4):2705-14. PubMed ID: 26264164 [TBL] [Abstract][Full Text] [Related]
33. ERCC polymorphisms and prognosis of patients with osteosarcoma. Li J; Liu S; Wang W; Zhang K; Liu Z; Zhang C; Chen S; Wu S Tumour Biol; 2014 Oct; 35(10):10129-36. PubMed ID: 25023406 [TBL] [Abstract][Full Text] [Related]
34. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. Ryu JS; Hong YC; Han HS; Lee JE; Kim S; Park YM; Kim YC; Hwang TS Lung Cancer; 2004 Jun; 44(3):311-6. PubMed ID: 15140544 [TBL] [Abstract][Full Text] [Related]
35. Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-à-vis chemotherapy drug cytotoxicity in human glioma. Chen H; Shao C; Shi H; Mu Y; Sai K; Chen Z J Neurooncol; 2007 May; 82(3):257-62. PubMed ID: 17151930 [TBL] [Abstract][Full Text] [Related]
36. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies. Qian T; Zhang B; Qian C; He Y; Li Y Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298 [TBL] [Abstract][Full Text] [Related]
37. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk. Zhou CX; Zhao JH Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436 [TBL] [Abstract][Full Text] [Related]
38. ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes. Lu X; Liu Y; Yu T; Xiao S; Bao X; Pan L; Zhu G; Cai Y; Liu Q; Jin C; Yang J; Wu S; An L; van der Straaten T PLoS One; 2013; 8(4):e60006. PubMed ID: 23593158 [TBL] [Abstract][Full Text] [Related]
39. Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer. Li F; Sun X; Sun N; Qin S; Cheng H; Feng J; Chen B; Cheng L; Lu Z; Ji J; Zhou Y Am J Clin Oncol; 2010 Oct; 33(5):489-94. PubMed ID: 20351547 [TBL] [Abstract][Full Text] [Related]
40. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization. Wang XC; Wang F; Quan QQ Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]